Form Type: 4

SEC EDGAR Link
Accession Number:0000899243-21-009374
Date:2021-03-01
Issuer: ITEOS THERAPEUTICS, INC. (ITOS)
Original Submission Date:

Reporting Person:

LAGER JOANNE JENKINS
C/O ITEOS THERAPEUTICS, INC.
139 MAIN STREET CAMBRIDGE, MA 02142

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
STOCK OPTION (RIGHT TO BUY) 41.58 2021-03-01 deemed execution date A 122,000 (a) 2031-03-01 common stock 122,000 $41.58 122,000 direct
Footnotes
IDfootnote
f1 this stock option shall vest over 4 years, with 25% vesting on march 1, 2022 and thereafter in equal monthly installments over the next 36 months subject to the reporting person's continued service to the issuer.

Elevate your investments